Bernhard Babel is the founder of Avextra. Avextra has raised $22M in total funding. Based in Bensheim, Germany.
Bernhard Babel is the CEO of Avextra, a German medical cannabis company. The company focuses on the entire value chain from cultivation to manufacturing and developing pharmaceutical-grade, cannabis-based medicines. Under his leadership, Avextra secured an investment round totaling over 20 million euros in early 2024.
Full founder directory · Investor directory · Company funding database · Fundraising library